(a) The Secretary, in consultation with the Board, shall adopt regulations to carry out this subtitle. (b) The regulations adopted by the Secretary shall: (1) Specify the prescription monitoring data and naloxone medication data required to be submitted under § 21-2A-03 of this subtitle; (2) Specify the electronic or other means by which information is to be submitted: (i) Without unduly increasing the workload and expense on dispensers; and (ii) In a manner as compatible as possible with existing data submission practices of dispensers; (3) Specify that the information be submitted by dispensers once every 24 hours; (4) Specify that the Program: (i) Shall provide the information technology software to dispensers necessary to upload prescription drug monitoring data and naloxone medication data to the Program; and (ii) May not impose any fees or other assessments on prescribers or dispensers to support the operation of the Program; (5) Identify the mechanism by which: (i) Prescription monitoring data are disclosed to a person, in accordance with § 21-2A-06 of this subtitle; and (ii) Naloxone medication data are disclosed to a person, in accordance with § 21-2A-06.1 of this subtitle; (6) Identify the circumstances under which a person may disclose prescription monitoring data or naloxone medication data received under the Program; (7) Specify the process for the Program's review of prescription monitoring data and naloxone medication data and reporting of: (i) Possible misuse or abuse of a monitored prescription drug under § 21-2A-06(c) of this subtitle; or (ii) A possible violation of law or possible breach of professional standards under § 21-2A-06(d) of this subtitle; (8) Establish requirements for Program retention of prescription monitoring data and naloxone medication data for 3 years; and (9) Require that: (i) Confidential or privileged patient information be kept confidential; and (ii) Records or information protected by a privilege between a health care provider and a patient, or otherwise required by law to be held confidential, be filed in a manner that, except as otherwise provided in §§ 21-2A-06 and 21-2A-06.1 of this subtitle, does not disclose the identity of the person protected.
‹ Prev All Maryland sections Next ›
Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.